Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases ...Middle East

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, July 12, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi...

Hence then, the article about sirnaomics announces completion of ind enabling studies of safety and efficacy for stp125g with nhp models targeting apoc3 for treatment of cardiovascular diseases was published today ( Friday 12/07/2024 - 11:37 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases )

Also on site :

• BURNHAM PARK CAPITAL MARKETS LAUNCHES AS CHICAGO'S NEWEST INVESTMENT BANK, WILL CONSOLIDATE FIVE SPECIALIZED FIRMS TO CREATE A FULL SERVICE PLATFORM
• Marcello Hernández to Host 2026 ESPYS
• Ueda Says BOJ Needs to Keep Raising Rates to Contain Inflation